Evidence map›Paper›PMID 38495400›Full record

ArticleWellcome open research2023

Aortic flow is abnormal in HFpEF.

Zia Mehmood, Hosamadin Assadi, Rui Li, Bahman Kasmai, Gareth Matthews, Ciaran Grafton-Clarke, Aureo Sanz-Cepero, Xiaodan Zhao, Liang Zhong, Nay Aung and 9 more

Open access · goldAbstract read
In one paragraph

Article in Wellcome open research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 4 countries.

Zia MehmoodDepartment of Cardiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, NR4 7UY, UK.ORCID https://orcid.org/0000-0002-1142-7574
Hosamadin AssadiDepartment of Cardiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, NR4 7UY, UK.ORCID https://orcid.org/0000-0002-6143-8095
Rui LiDepartment of Cardiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, NR4 7UY, UK.
Bahman KasmaiDepartment of Cardiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, NR4 7UY, UK.ORCID https://orcid.org/0009-0008-5257-511X
Gareth MatthewsDepartment of Cardiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, NR4 7UY, UK.
Ciaran Grafton-ClarkeDepartment of Cardiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, NR4 7UY, UK.
Aureo Sanz-CeperoDepartment of Cardiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, NR4 7UY, UK.
Xiaodan ZhaoNational Heart Research Institute, National Heart Centre Singapore, Singapore, 169609, Singapore.ORCID https://orcid.org/0000-0003-1469-8027
Liang ZhongNational Heart Research Institute, National Heart Centre Singapore, Singapore, 169609, Singapore.
Nay AungWilliam Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, London, EC1M 6BQ, UK.ORCID https://orcid.org/0000-0001-5095-1611
Kristian SkinnerDepartment of Cardiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, NR4 7UY, UK.
Charaka HadinnapolaDepartment of Cardiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, NR4 7UY, UK.ORCID https://orcid.org/0000-0002-7794-3432
Peter SwobodaDivision of Biomedical Imaging, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, LS2 9JT, UK.ORCID https://orcid.org/0000-0001-7162-7079
Andrew J SwiftDepartment of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.ORCID https://orcid.org/0000-0002-5483-169X
Vassilios S VassiliouDepartment of Cardiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, NR4 7UY, UK.ORCID https://orcid.org/0000-0002-4005-7752
Christopher MillerDivision of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Rob J van der GeestDepartment of Radiology, Division of Image Processing, Leiden University Medical Center, Leiden, 2300 RC, The Netherlands.ORCID https://orcid.org/0000-0002-9084-5597
Steffen PetersonWilliam Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, London, EC1M 6BQ, UK.ORCID https://orcid.org/0000-0003-4622-5160
Pankaj GargDepartment of Cardiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, NR4 7UY, UK.ORCID https://orcid.org/0000-0002-5483-169X
University College Dublin · IESt Bartholomew's Hospital · GBLeiden University Medical Center · NLManchester Academic Health Science Centre · GBNational Heart Centre Singapore · SGNational University of Singapore · SGUniversity of Leeds · GBUniversity of Sheffield · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Aims: Turbulent aortic flow makes the cardiovascular system less effective. It remains unknown if patients with heart failure with preserved ejection fraction (HFpEF) have disturbed aortic flow. This study sought to investigate advanced markers of aortic flow disturbances in HFpEF. Methods: This case-controlled observational study used four-dimensional flow cardiovascular magnetic resonance derived, two-dimensional phase-contrast reformatted plane data at an orthogonal plane just above the sino-tubular junction. We recruited 10 young healthy controls (HCs), 10 old HCs and 23 patients with HFpEF. We analysed average systolic aortic flow displacement (FDsavg), systolic flow reversal ratio (sFRR) and pulse wave velocity (PWV). In a sub-group analysis, we compared old HCs versus age-gender-matched HFpEF (N=10). Results: Differences were significant in mean age (P<0.001) among young HCs (22.9±3.5 years), old HCs (60.5±10.2 years) and HFpEF patients (73.7±9.7 years). FDsavg, sFRR and PWV varied significantly (P<0.001) in young HCs (8±4%, 2±2%, 4±2m/s), old HCs (16±5%, 7±6%, 11±8m/s), and HFpEF patients (23±10%, 11±10%, 8±3). No significant PWV differences existed between old HCs and HFpEF.HFpEF had significantly higher FDsavg versus old HCs (23±10% vs 16±5%, P<0.001). A FDsavg > 17.7% achieved 74% sensitivity, 70% specificity for differentiating them. sFRR was notably higher in HFpEF (11±10% vs 7±6%, P<0.001). A sFRR > 7.3% yielded 78% sensitivity, 70% specificity in differentiating these groups. In sub-group analysis, FDsavg remained distinctly elevated in HFpEF (22.4±9.7% vs 16±4.9%, P=0.029). FDsavg of >16% showed 100% sensitivity and 70% specificity (P=0.01). Similarly, sFRR remained significantly higher in HFpEF (11.3±9.5% vs 6.6±6.4%, P=0.007). A sFRR of >7.2% showed 100% sensitivity and 60% specificity (P<0.001). Conclusion: Aortic flow haemodynamics namely FDsavg and sFRR are significantly affected in ageing and HFpEF patients.

Indexed as

Aortic FlowCardiac OutputHaemodynamicsHFpEFMagnetic Resonance Imaging

Identifiers

PMID38495400
PMCPMC10940846
OpenAlexW4392519822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.